Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy and Long-term Outcomes of Allograft Versus Stented Biological Prosthesis for Primary Tricuspid Valve Disease

NCT06591000 is registered in ClinicalTrials.gov with Chelyabinsk Regional Clinical Hospital as lead sponsor.

NCT NCT06591000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06591000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy and Long-term Outcomes of Allograft Versus Stented Biological Prosthesis for Primary Tricuspid Valve Disease
Lead sponsor
Chelyabinsk Regional Clinical Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 14, 2016
Completion date
June 14, 2025
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allograft, bioprosthesis, tricuspid valve disease